pilocarpine has been researched along with Coronary Disease in 2 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiatt, RL | 1 |
| Deutsch, AR | 1 |
| Ringer, C | 1 |
| Kimura, K | 1 |
2 other studies available for pilocarpine and Coronary Disease
| Article | Year |
|---|---|
Low tension glaucoma.
Topics: Aged; Bronchitis; Carbachol; Cardiovascular Diseases; Coronary Disease; Diabetes Complications; Fema | 1971 |
Pathophsiological significance of sympathetic activity in cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Output; Cardiovascular Diseases; Coronar | 1974 |